Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients
Journal of Autoimmunity2015Vol. 62, pp. 67–74
Citations Over TimeTop 1% of 2015 papers
Hélène Vallet, Sophie Rivière, Alice Sanna, Alban Deroux, Guillaume Moulis, Olga Addimanda, Carlo Salvarani, M. Lambert, P. Bielefeld, P. Sève, Jean Sibilia, JL Pasquali, Jb Fraison, I. Marie, L. Pérard, Laurence Bouillet, F. Cohen, D. Sène, Y. Schoindre, Olivier Lidove, P. Le Hoang, É. Hachulla, Olivier Fain, Xavier Mariette, T. Papo, B. Wechsler, Bahram Bodaghi, M.Resche Rigon, P. Cacoub, David Saadoun
Related Papers
- → Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis(2008)377 cited
- → Effectiveness of infliximab after adalimumab failure in Crohn's disease.(2012)32 cited
- Effectiveness of infliximab after adalimumab failure in Crohn＇s disease(2012)
- → Costs of adalimumab versus infliximab as first-line biological therapy for luminal Crohn's disease(2013)17 cited
- → SAFETY PROFILE OF ANTI-TNF THERAPY IN CROHN’S DISEASE MANAGEMENT: A BRAZILIAN SINGLE-CENTER DIRECT RETROSPECTIVE COMPARISON BETWEEN INFLIXIMAB AND ADALIMUMAB(2017)14 cited